CD164

Across TCGA patient cohorts, CD164 mutation is significantly associated with the RNA expression of many other genes, with 767 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CD164-associated genes across cancer lineages are RN7SKP104, OR51A6P, and MIR4286. Each is linked with CD164 in more than 1 cancer types. Because this analysis shows association rather than direction, both CD164-to-partner and partner-to-CD164 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RN7SKP104 grouped by CD164-low versus CD164-high in SKCM.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CD164→partner) and Y-score (partner→CD164) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	RN7SKP104 →	+0.099	+7.816	<.001	.008	3	2
UCEC	OR51A6P →	+0.039	+3.290	.004	.005	3	2
KIRP	MIR4286 →	+0.332	+5.376	.002	.005	3	1
SKCM	RNU6-99P →	+0.463	+7.816	<.001	.008	3	1
SKCM	FAM197Y5 →	+0.049	+7.816	<.001	.008	3	1
UCEC	SMIM28 →	+0.604	+2.700	<.001	.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 767 associations by consensus.

RN7SKP104 by CD164 expression — SKCM

Explore this box plot interactively →